Showing 461-470 of 8821 results for "".
Eczema Discovery; Ortho Dermatologics, Revision, Alastin Product Launches
https://practicaldermatology.com/topics/practice-management/dermwiretv-eczema-discovery-ortho-dermatologics-revision-alastin-product-launches/18353/Regeneron revealed that Dupixent generated sales of $120M within the first nine months of launch. Researchers have identified a possible treatment for moderate-to-severe atopic dermatitis: IL-22 blockade. Product launches or updates from Revision Skincare, Alastin Skincare, Ortho Dermatologics, andAllergan Board Rejects Latest Valeant Bid; Topical Jublia Approved for Onychomycosis
https://practicaldermatology.com/series/dermwire-tv/dwtv-6-12/19122/Allergan's board rejects the latest merger proposal from Valeant and the FDA approves topical Jublia for onychomycosis. LEarn about these developments and hear from the AMA's new president in this edition of DermWireTV.My Lumixyl Experience
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/my-lumixyl-experience/19444/A patient of Dr. Ashish Bhatia's, describes her experience using Lumixyl Brightening System for her adult acne.The New Vbeam Prima: One Laser System with Endless Potential
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/syneron-v-beam-webinar/19600/Join Gilly Munavalli, MD as he presents an overview of Candela’s newly introduced and powerful Vbeam Prima laser platform and shares his personal experience and successes with the system. Dr. Munavalli will discuss the benefits of the Vbeam Prima’s dual wavelengths and dual cooling options to treatAchieving Optimal Outcomes with Laser Surgery
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/achieving-optimal-outcomes-with-laser-surgery/18818/Eric Bernstein, MD discusses a variety of laser and light devices and their benefits in treating a myriad of dermatological conditions as well as for cosmetic concerns. He also shares tips for how to use the devices safely to ensure optimal outcomes and to avoid adverse events.An Off-Label Adjuvant Treatment for Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermtube-journal-club-alam-part-2/18642/In part two of DermTube Journal Club Host Dr. Joshua Zeichner's interview with Murad Alam, MD, they talk about the role of imiquimod as an adjuvant therapy in treating melanoma. Dr. Alam describes how he uses imiquimod off-label after removing melanoma to help prevent recurrence. He also shares howAnonymous Reviews on Google+ and How They Impact Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/anonymous-reviews-on-google-and-how-they-impact-your-dermatology-practice/18827/Online reviews are a fact of modern medical practice. Many physicians fret over negative reviews, but what about positive reviews? Learn how reviews influence your search rankings, how patients assess reviews, and how you can create a Google+ page that allows for anonymous reviews of your practice.Off-label Uses for Biologics
https://practicaldermatology.com/topics/psoriasis/off-label-uses-for-biologics/18964/Derm Insider Bonus Content: Host Neal Bhatia speaks with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD about various potential off-label uses for current and investigational systemic psoriasis therapies.Join Us for NewDerm LIVE: Welcome from the Chairs
https://practicaldermatology.com/topics/practice-management/join-us-for-newderm-live-welcome-from-the-chairs/18920/Join us September 18-20, 2015 at the W Hollywood, CA for NewDerm Live, the meeting that's focused on you—so you can focus on your future. Program chairs Sabrina Fabi, MD, Peter Lio, MD, and Kavita Mariwalla, MD, talk about the goals of the meeting and explain why they decided to be part of this exciGuys Don't Be Like Paul
https://practicaldermatology.com/topics/skin-cancer-photoprotection/guys-don-t-be-like-paul/18923/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The first PSA and video focuses specifically on men and features Dr. Keaney. Data from the Skin Cancer Foundation cited by ASDS show that only 30 percent of American men are